Inbal Houri
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 2
- Obstetrics and Gynecology top 5%
- COVID-19 Impact on Reproduction 2
- Transplantation top 10%
- Health top 10%
- Animal Science and Zoology top 5%
-
- Liver Disease Diagnosis and Treatment 4
- Hepatitis B Virus Studies 3
-
- Hepatitis C virus research 4
- Liver Diseases and Immunity 2
-
- Pediatric Hepatobiliary Diseases and Treatments 2
In The Last Decade
Inbal Houri
13 papers receiving 534 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Infectious Diseases 474
- Obstetrics and Gynecology 123
- Transplantation 31
- Health 90
- Animal Science and Zoology 102
Countries citing papers authored by Inbal Houri
This map shows the geographic impact of Inbal Houri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inbal Houri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inbal Houri more than expected).
Fields of papers citing papers by Inbal Houri
This network shows the impact of papers produced by Inbal Houri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inbal Houri. The network helps show where Inbal Houri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inbal Houri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 15 | |
| 6 | Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipientsbreakdown → | 2021 | 226 |
| 7 | Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virusbreakdown → | 2021 | 242 |
| 8 | 2021 | 4 | |
| 9 | 2021 | 22 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2001 | 1 |
About Inbal Houri
Inbal Houri is a scholar working on Hepatology, Infectious Diseases and Transplantation, having authored 14 papers that have together received 543 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Hepatitis C virus research (4 papers), Hepatitis B Virus Studies (3 papers), Liver Diseases and Immunity (2 papers), COVID-19 Clinical Research Studies (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers) and COVID-19 Impact on Reproduction (2 papers). The work is most often cited by research in Infectious Diseases (474 citations), Obstetrics and Gynecology (123 citations) and Transplantation (31 citations). Inbal Houri has collaborated with scholars based in Israel, Finland and Canada. Frequent co-authors include Oren Shibolet, Helena Katchman, Tami Halperin, Roni Baruch, Liane Rabinowich, Eugene Katchman, Dan Turner, Ayelet Grupper, Merav Ben‐Yehoyada and Sharon Levi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.